Menu
Menu
Hironobu Oonishi Memorial Award of ISCM sponsored by Kyocera Co.
Dr. Hironobu Oonishi passed on November1st, 2014 at 79 years old. He was one of the founders of International Society for Ceramic held at Medicine and the Co-chairperson of 1st annual meeting of ISCM In Kyoto, Japan. He was an excellent hip surgeon and was well known that he discovered that irradiated polyethylene had the resistance against wear in joint replacements. Kyocera Co agreed to sponsor Hironobu Ohnishi Memorial Award. The award is given to a researcher who contributed to clinical field of bioceramics and contributed to ISCM. The awardee will get an award shield and 300 thousand yen. The awardee is selected by selection committee headed by Dr Hiroshi Oonishi who is a son of Dr. Hironobu Oonish. One awardee is selected each meeting and the award will close after selection of ten awardees.
Professor of Bioengineering and Professor of Orthopaedic Surgery Research at the University of Pennsylvania, Philadelphia, PA, USA.
Paul Ducheyne, Professor of Bioengineering and Professor of Orthopaedic Surgery Research at the University of Pennsylvania, Philadelphia, PA, USA, was Director of its Center for Bioactive Materials and Tissue Engineering. He was a Special Guest Professor at the KU Leuven, Belgium. Paul Ducheyne is also Founder and President of XeroThera, a spin-out from Penn, that is developing advanced controlled delivery concepts for prophylaxis and treatment of surgical infections.
Professor Ducheyne has been a leading scientist in the field of biomaterial research for decades, with seminal contributions to biomaterials research, especially as it relates to orthopaedics. In bioceramics research, he clearly delineated the unusual properties of engineered bioactive ceramics. Not only was he at the vanguard of the development of these materials, he also generated a fundamental understanding of how these materials exhibit bone bioactive properties and promote skeletal healing. His group has also studied inorganic controlled release materials and has demonstrated the utility of sol-gel synthesized silica-based nanoporous materials for therapeutic use. These materials may well represent a next generation of agents for delivery of drugs, including antibiotics, analgesics, and osteogenic and anti-inflammatory molecules.
Paul Ducheyne graduated from the KU Leuven in Materials Science and Engineering. As an NIH International Postdoctoral Fellow, he performed research at the University of Florida. Upon his return to the KU Leuven, he was one of the co-founders of the Post-Graduate Curriculum in Bioengineering and organized the Fourth European Conference on Biomaterials (1983). Other significant meetings under his purview followed soon after joining Penn, including the Engineering Foundation Conference on Bioceramics (1986) and the 6th International Symposium on Ceramics in Medicine (1993).
Professor Ducheyne has lectured around the world and has served on the editorial board of countless scientific journals in the biomaterials, bioceramics, bioengineering, tissue engineering, orthopaedics and dental fields. He was a member of the editorial board, and then an Associate Editor of Biomaterials (Elsevier) since its inception in the late 1970s. His papers have been cited more than 14,500 times with an “h-factor” of 68; his ten most visible papers have been cited more than 3,600 times. He has edited 16 books and book volumes and is Editor-in-Chief of Comprehensive Biomaterials, a 7-volume, 4,850-page major reference work published by Elsevier (2011, 2017).
Paul Ducheyne founded Orthovita, the first osteobiologics company to become publicly listed. Orthovita was the leading, independent biomaterials company in the world with more than 250 employees at the time of its acquisition by Stryker in June 2011. He also founded Gentis, Inc., which focuses on breakthrough concepts for spinal disorders, and XeroThera.
Many of Ducheyne’s PhD students and postdoctoral fellows have become leaders of the next generation. Among his students are Professors at UC Berkeley, the University of Michigan, Columbia University, Georgia Institute of Technology, Kyushu University, the KU Leuven and other. Among nine Associate Editors of the Journal for Biomedical Materials Research, three were his PhD students.
Paul Ducheyne has been Secretary of the European Society for Biomaterials, is Past President of the Society for Biomaterials (USA) and of the International Society for Ceramics in Medicine. He has been recognized as a fellow of the American Association for the Advancement of Science (AAAS), fellow of the American Institute of Medical and Biological Engineering (AIMBE), and fellow of the International Association of Biomaterials Societies. He was the first Nanyang Visiting Professor at the Nanyang Institute of Technology, Singapore. He has received the C. William Hall Award from the Society for Biomaterials, as well as its Founders Award for his “long-term, landmark contributions to the discipline of biomaterials”. He has been awarded the Inaugural Bioceramics Pioneer Award by the International Society for Ceramics in Medicine for “outstanding lifetime achievements”, he is recipient of ESB’s International Award 2019 and he receives the this year’s Hironobu Oonishi Memorial Award of ISCM.
School of Mechanical and Materials Engineering, Affiliate faculty, Department of Chemistry & Elson Floyd College of Medicine, Washington State University, USA
Susmita Bose is a Westinghouse Distinguished Professor of the School of Mechanical and Materials Engineering, affiliate faculty of Chemistry, and Elson Floyd College of Medicine at Washington State University. She received a BS from Kalyani University, an MS from the Indian Institute of Technology (IIT) – Kanpur in Chemistry, and a Ph.D. from Rutgers University, New Jersey, USA, in 1998. In the spring of 2008, 2014, and 2021 she was a Visiting Professor at Harvard University at the School of Engineering and Applied Sciences (SEAS, Cambridge, MA), and at the Materials Science and Engineering (MSE), Georgia Institute of Technology (Atlanta, GA). Prof. Bose’s interdisciplinary research interest lies at the interface of Chemistry, Materials Science, Mechanical Engineering, and Biology, focusing on 3D-printed bioceramic bone scaffolds, bioceramic-coated metal implants, and drug delivery vehicles.
Prof. Bose is a fellow of the American Association for the Advancement of Science (AAAS), National Academy of Inventors (NAI), Materials Research Society (MRS), ASM International, American Institute for Medical and Biological Engineering (AIMBE), American Ceramic Society (ACerS), Royal Society of Chemistry (RSC) and an elected member of the Washington State Academy of Sciences. She received the NSF CAREER award and the prestigious Presidential Early Career Award for Scientists and Engineers (PECASE) at the White House, given by the US President in WA, DC. She has advised over 45 MS and Ph.D. students and published over 300 technical articles, including >260 journal articles, 24 book chapters, 9 edited books, 13 issued patents, citations over 29,300 times, “h” index 87 (Google scholar, 02/2023). She received the PACE and Fulrath Awards from the American Ceramic Society. Prof. Bose received WSU distinguished faculty award and the Sahlin faculty excellence award for research scholarships and art. Her group’s research on 3D-printed ceramic bone scaffolds and natural medicinal compounds has been featured by the AP, BBC, NPR, CBS News, MSNBC, ABC News, and many other TV, radio stations, magazines, and news sites all over the world, including R&D magazine, Science Daily News, etc.
Matthias Epple is Professor of Inorganic Chemistry at the University of Duisburg-Essen (Germany). He obtained his PhD in 1992 at the Technical University of Braunschweig. After postdoctoral studies at the University of Washington (Seattle, USA) and the Royal Institution (London, UK), he went to the University of Hamburg where he obtained his Habilitation in 1997. He was Professor at the Universities of Augsburg and Bochum before moving to the University of Essen. His research interests comprise the synthesis and biomedical application of inorganic nanoparticles, namely calcium phosphate and noble metals, for gene and drug delivery. Such nanoparticles can be applied to manipulate cells, e.g. to stimulate bone growth, to induce an immune response (vaccination), or to downregulate inflammatory proteins. Matthias Epple is a past President of the German Society for Biomaterials and has published more than 540 papers in international journals.
University Clinics of Dental Medicine, University of Geneva, Geneva, Switzerland
Professor Susanne Scherrer received her D.D.S (1984), her doctorate (1986) and her Privat Docent (2003) from the University Clinics of Dental Medicine, University of Geneva, Switzerland.
She is Full Professor in the Division of Fixed Prosthodontics-Biomaterials, Head of Biomaterials and Head of Continuing Education. Prof. Scherrer is the current President of the University Clinics of Dental Medicine (2022-2025). She is a Fellow of the Academy of Dental Materials and Academy of Prosthodontics. She has served as President of the Academy of Dental Materials (2002-2004), and President of the Dental Materials Group of the IADR (2001-2002). In 2014 she was awarded the IADR-Distinguished Scientist Wilmer Souder Award from the Dental Materials Group.
Her primary area of research and publishing involves dental ceramics, mechanical properties, clinical longitudinal trials and failure analysis using fractography. She has worked as a general practitioner from 1984 until 2015 in extramural family private practices half of her time. She currently serves on the Editorial Boards of the JADA Foundation Science, and the Swiss Dental Journal.
Professor Orthopedic Surgery, Pharmacology, Pathology & Pediatrics; Jeffrey W. Mast Chair in Orthopaedic Trauma and Hip Surgery; Associate Director Vanderbilt Center for Bone Biology; Office of Surgeon in Chief Director Innovation and Education; Medical Director Surgery and Acute Care; Vanderbilt University Medical Center; Nashville, USA
I am an orthopaedic surgeon committed to improving the quality of life of children with musculoskeletal disorders. My clinical focus is on pediatric hip surgery, trauma, and infection. My role in pediatric orthopaedics is multifaceted, including a patient-focused clinical practice, leadership, teaching, mentorship, and running a productive translational research program. My dual training in surgery and basic science gives me the unique opportunity to improve the lives of patients through direct clinical care while also conducting impactful translational research. Additionally, I have established a focused translational research program that works in tandem with clinical orthopaedic practice by concentrating on the most significant clinical issues in musculoskeletal medicine that have limited effective medical and/or surgical solutions. This program aims to improve the care of problems often presented at orthopaedic morbidity and mortality conferences. To this end, our program’s research is designed to investigate the body’s response to tissue injury, known as the ‘acute phase response’, and the biology of musculoskeletal tissue development, repair, and. Developing novel approaches to preventing and treating these conditions is essential, as they account for most of the medical and physical problems with the greatest morbidity and mortality in patients with musculoskeletal disease. In summary, I am humbled and immensely satisfied in caring for children and their families who require orthopaedic acute care. My mission is to improve care through collaborative efforts where I can help find groundbreaking solutions for the issues we can currently not fix with medicine or surgery.
Department of Chemistry, Zhejiang University, China
Prof. Ruikang Tang is a Qiushi Distinguished Professor of Zhejiang University, China. His research focuses on bio-inspired preparations of materials and their applications in biomedicine. One of his representative achievements is the establishment of a new concept of inorganic ionic polymerization/crossing, which ensures moldable manufacture of bioceramics and provides a novel strategy for hard tissue regenerations.
October 17-20, 2023
October 16-17, 2023
